6446.TW Stock — Price, Charts & Analysis

PharmaEssentia Corporation (6446.TW) has a trailing P/E of 75.76x and a forward P/E of 38.03x. This places 6446.TW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

6446.TW trades with 75.76x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether 6446.TW looks overvalued or undervalued.

6446.TW's P/E of 75.76x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

6446.TW's trailing EPS is NT$18.15 and forward EPS is NT$36.16. Reported earnings growth is 203.50%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit PharmaEssentia Corporation generated for each share. 6446.TW's trailing EPS is NT$18.15, and investors usually prefer EPS that is positive and growing over time.

PharmaEssentia Corporation has a market cap of NT$568.03B, making 6446.TW a large-cap stock based on the current market value shown on Worldtickers.

6446.TW's latest stock price on Worldtickers is NT$1,375.00. The latest move is -NT$25.00 or -1.79%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

6446.TW's quote includes a latest price of NT$1,375.00. The market open is NT$1,435.00. Previous close is NT$1,400.00. The intraday range is NT$1,370.00 to NT$1,450.00.

6446.TW is down in the latest quote, with a move of -NT$25.00 or -1.79%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

6446.TW generated NT$20.75B in trailing revenue. Revenue growth is 90.30%, which helps show whether demand is expanding or slowing.

6446.TW's revenue growth is 90.30%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, 6446.TW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is NT$7.63B.

Gross margin is 90.90%. Margins show how efficiently PharmaEssentia Corporation turns revenue into profit.

PharmaEssentia Corporation carries NT$1.02B and holds NT$24.47B in cash.

6446.TW holds NT$24.47B on its balance sheet.

6446.TW's book value per share is NT$88.84.

Yes, PharmaEssentia Corporation pays a dividend of NT$1.49 per share annually. The dividend yield is 11.00%. The payout ratio is 4.84%.

6446.TW's dividend yield is 11.00%. Its payout ratio is 4.84%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for 6446.TW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through PharmaEssentia Corporation's investor relations materials.

Institutions hold 20.15% of 6446.TW shares. Insiders hold 13.66% of shares. Ownership mix helps investors understand how much of PharmaEssentia Corporation is held by professional investors and company insiders.

6446.TW has 413.11M shares outstanding. Float shares are 330.53M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for 6446.TW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for 6446.TW is NT$36.16. Earnings growth is 203.50%. Revenue growth is 90.30%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

6446.TW's trailing EPS is NT$18.15. Forward EPS is NT$36.16. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

6446.TW is in the Healthcare sector. Its earnings multiple is 75.76x. Its latest displayed growth metric is 90.30%. Compare these figures with sector peers before deciding whether PharmaEssentia Corporation is stronger or weaker than average.

6446.TW trades at NT$1,375.00. The stock trades at 75.76x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of PharmaEssentia Corporation's fundamentals.

6446.TW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.61, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

6446.TW should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 75.76x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

PharmaEssentia Corporation (6446.TW) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the tr

6446.TW trades on Taiwan. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

6446.TW stock is priced in TWD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

PharmaEssentia Corporation's official website listed on Worldtickers is www.pharmaessentia.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

PharmaEssentia Corporation is headquartered in Taipei, Taiwan. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

6446.TW is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

6446.TW has traded between NT$398.05 and NT$1,550.00 over the past 52 weeks. At NT$1,375.00, it is 11.29% below the high and 245.43% above the low. The 52-week range helps gauge long-term price momentum.

6446.TW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is NT$1,192.90 and its 200-day moving average is NT$724.33.

6446.TW's RSI is 57.23. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

6446.TW's latest RSI reading is 57.23, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for 6446.TW is near NT$1,015.00. Key resistance is near NT$1,550.00. Breaks above resistance or below support can change the short-term technical setup.

6446.TW's nearest reported support level is NT$1,015.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

6446.TW's nearest reported resistance level is NT$1,550.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

6446.TW trades about 3.36M shares daily on average. The latest displayed volume is 2.52M shares. Volume helps show liquidity and whether trading interest is unusually high or low.

6446.TW's MACD is 4.66, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

6446.TW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 57.23 (neutral). MACD is bullish. Nearest support is around NT$1,015.00. Resistance is around NT$1,550.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is NT$1,280.75 (7.36% from price). MA50 is NT$1,192.90 (15.27% from price). MA200 is NT$724.33 (89.83% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. 6446.TW's MA20 is NT$1,280.75. MA50 is NT$1,192.90. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

6446.TW's pivot is near NT$1,401.67. Support is near NT$1,015.00. Resistance is near NT$1,550.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for 6446.TW is near NT$1,186.67. The next upper resistance zone is near NT$1,547.50. These levels help define risk and possible follow-through zones after a breakout or breakdown.

6446.TW's Bollinger range is roughly NT$990.26 to NT$1,571.24. Band width is near 45.36%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

6446.TW's ATR-based typical daily range is about 6.67%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 2.52M shares. Average volume is about 3.36M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

6446.TW's all-time high shown on Worldtickers is NT$1,550.00. Its all-time low is NT$35.58. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

6446.TW has a beta of 0.61, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.